MENU
GET LISTED
GET LISTED
SHOW ALLPOPULAR CATEGORIES

Compare Heartpace vs Effy

SCORES FEATURES PRICING PRICING MODEL INTEGRATIONS

What is better Heartpace or Effy? You can use our scoring system to provide you with a general idea which Performance Appraisal Software product is more suitable for your company. For overall product quality, Heartpace received 8.0 points, while Effy earned 8.0 points. At the same time, for user satisfaction, Heartpace scored 100%, while Effy scored 93%.

Specifics of their functions, tools, supported platforms, customer support, etc. are available below to provide you with a more precise analysis. Remember to purchase only the features that you need to avoid wasting resources for functions that are unnecessary.

Currently, the leading services in our HR Management Software category are: Zoho People, Gusto HR, BambooHR.

All the data, details and opinions that we provided in this comparison were collected from official vendor websites, advertising materials available online, actual experience from real users as well as our personal direct use of every product by a professional reviewer. We pay a lot of attention to comprehensively analyze each software, as a result we not only analyze it internally, but we also correlate our results with views of other users from the B2B community.

Page last modified

Why is FinancesOnline free? Why is FinancesOnline free?

FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.